Thermo Fisher Advances Gene Therapy with DeltaV Automation

Thermo Fisher

Prajakta Bhanap of Thermo Fisher Scientific discussed the company’s creation of Cellmation, a digital solution that dramatically streamlines the manufacture of cell therapies. For decades, the foundations of cancer treatment have been surgery, chemotherapy and radiation therapy. These continue to be critical mainstays of treatment, but in recent years new categories of treatment have helped transform the treatment outlook for many people with cancer.

Latest News

Emerson Ventures Invests in Symmera

Emerson today announced it has made a strategic investment through its corporate venture capital arm Emerson Ventures in Symmera, an early-stage...

Emerson Ventures Invests in First Resonance

Strategic investment from Emerson’s corporate venture capital arm supports First Resonance's ION Factory Operating System

Emerson Ventures Makes Strategic Investment in Spearix

Emerson has made a strategic investment through Emerson Ventures, its corporate venture capital arm, in Spearix Technologies, Inc., whose...
Please enable JavaScript to use this website.